176 related articles for article (PubMed ID: 24321200)
41. Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer.
Yang X; Gao F; Ma F; Ren Y; Chen H; Liang X; Han S; Xiong X; Pan W; Zhou C; Zhou L; Yang M
Tumour Biol; 2016 Feb; 37(2):1693-8. PubMed ID: 26311051
[TBL] [Abstract][Full Text] [Related]
42. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
[TBL] [Abstract][Full Text] [Related]
43. Comparison of antidepressant efficacy-related SNPs among Taiwanese and four populations in the HapMap database.
Chi MH; Lee SY; Chang HH; Yang YK; Lin E; Chen PS
J Formos Med Assoc; 2011 Jul; 110(7):478-82. PubMed ID: 21742253
[TBL] [Abstract][Full Text] [Related]
44. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
[TBL] [Abstract][Full Text] [Related]
45. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Wilkosc M; Skibinska M; Hauser J
J Affect Disord; 2011 Nov; 134(1-3):138-44. PubMed ID: 21764460
[TBL] [Abstract][Full Text] [Related]
46. Genetic predisposition to advanced biological ageing increases risk for childhood-onset recurrent major depressive disorder in a large UK sample.
Michalek JE; Kepa A; Vincent J; Frissa S; Goodwin L; Hotopf M; Hatch SL; Breen G; Powell TR
J Affect Disord; 2017 Apr; 213():207-213. PubMed ID: 28233563
[TBL] [Abstract][Full Text] [Related]
47. The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.
Calabrò M; Fabbri C; Crisafulli C; Albani D; Forloni G; Kasper S; Sidoti A; Velardi E; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Hum Psychopharmacol; 2018 Nov; 33(6):e2682. PubMed ID: 30426571
[No Abstract] [Full Text] [Related]
48. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.
Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ
Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687
[TBL] [Abstract][Full Text] [Related]
49. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
[TBL] [Abstract][Full Text] [Related]
50. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
Unschuld PG; Ising M; Roeske D; Erhardt A; Specht M; Kloiber S; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Jun; 35(7):1583-92. PubMed ID: 20237460
[TBL] [Abstract][Full Text] [Related]
51. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders.
Lee HJ; Cha JH; Ham BJ; Han CS; Kim YK; Lee SH; Ryu SH; Kang RH; Choi MJ; Lee MS
Pharmacogenomics J; 2004; 4(1):29-33. PubMed ID: 14647404
[TBL] [Abstract][Full Text] [Related]
52. Serotonin transporter gene polymorphisms and treatment-resistant depression.
Bonvicini C; Minelli A; Scassellati C; Bortolomasi M; Segala M; Sartori R; Giacopuzzi M; Gennarelli M
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):934-9. PubMed ID: 20450949
[TBL] [Abstract][Full Text] [Related]
53. Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.
Minelli A; Magri C; Barbon A; Bonvicini C; Segala M; Congiu C; Bignotti S; Milanesi E; Trabucchi L; Cattane N; Bortolomasi M; Gennarelli M
Transl Psychiatry; 2015 Dec; 5(12):e687. PubMed ID: 26624926
[TBL] [Abstract][Full Text] [Related]
54. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
[TBL] [Abstract][Full Text] [Related]
55. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
[TBL] [Abstract][Full Text] [Related]
56. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin.
Illi A; Viikki M; Poutanen O; Setälä-Soikkeli E; Nuolivirta T; Kampman O; Leinonen E; Huhtala H; Mononen N; Lehtimäki T
Psychiatr Genet; 2013 Feb; 23(1):33-5. PubMed ID: 23250003
[TBL] [Abstract][Full Text] [Related]
57. [Characterisation of three polymorphisms of the tryptophan hydroxylase 2 gene in a sample of Colombian population with major depressive disorder].
Martínez-Idárraga A; Riveros-Barrera I; Sánchez R; Jaramillo LE; Calvo-Gómez JM; Yunis-Londoño JJ
Rev Colomb Psiquiatr; 2017; 46(1):22-30. PubMed ID: 28193370
[TBL] [Abstract][Full Text] [Related]
58. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
59. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
[TBL] [Abstract][Full Text] [Related]
60. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
